Use of ChemoFx® for Identification of Effective Treatments in Epithelial Ovarian Cancer

Selection of appropriate chemotherapy, including identification of platinum resistance, is critical to effective management of advanced epithelial ovarian cancer (EOC). ChemoFx®, a multiple treatment marker (chemoresponse assay), has been developed to address this challenge and to improve outcomes i...

Descripción completa

Detalles Bibliográficos
Autores principales: Richard, Scott, Wells, Alan, Connor, Joseph, Price, Fredric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506277/
https://www.ncbi.nlm.nih.gov/pubmed/26213638
http://dx.doi.org/10.1371/currents.eogt.8b0b6fffc7b999b34bc4c8152edbf237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506277/
https://www.ncbi.nlm.nih.gov/pubmed/26213638
http://dx.doi.org/10.1371/currents.eogt.8b0b6fffc7b999b34bc4c8152edbf237

Ejemplares similares